Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre

Authors: Anke De-Masi, Esther Davis, Tamzin Cuming, Noreen Chindawi, Francesca Pesola, Carmelina Cappello, Susan Chambers, Julie Bowring, Adam N. Rosenthal, Peter Sasieni, Mayura Nathan

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

High resolution anoscopy (HRA) examination is regarded as the best method for the management of anal high grade squamous intraepithelial lesions to prevent anal squamous carcinoma. However, little is known about the acceptability of this procedure. This analysis looks at patient experience of HRA examination and ablative treatment under local anaesthetic.

Methods

Patients took part in anonymised feedback of their experience immediately after their HRA examinations and/or treatments. A standard questionnaire was used that included assessment of pain and overall satisfaction scores as well as willingness to undergo future HRA examinations.

Results

Four hundred four (89.4%) responses were received and all responses were analysed. The group consisted of 119 females (29.4%) and 261 males (64.6%) with median age of 45 years (IQR = 19) and 45 years (IQR = 21) respectively, and included 58 new cases, 53 treatment cases and 202 surveillance cases. 158 patients (39.1%) had at least one biopsy during their visits. The median pain score was 2 [Inter Quartile Range (IQR) 3] on a visual analogue scale of 0 to 10, where 0 indicated no pain / discomfort and 10 indicated severe pain. The median pain score was 2 (IQR 2) in men and 4 (IQR = 3) in women [Dunn’s Test = 4.3, p < 0.0001] and 3 (IQR 4.5) in treatment cases. Problematic pain defined as a pain score of ≥7 occurred more frequently in women (14%) than in men (6%), [Chi square test (chi2) = 5.6, p = 0.02]. Patient satisfaction with the care they received, measured on a scale of 0 (not happy) to 10 (very happy) found the median score to be 10 with 76% reporting a score of 10. Out of 360 responses, 98% of women and 99% of men said that they would be willing to have a future HRA examination.

Conclusions

In this cohort, the overall pain scores were low and similar across appointment types. However, women had a higher pain score, including troublesome pain levels. Despite this, both women and men were equally satisfied with their care and were willing to have a future examination. The results of the analysis show that the procedure is acceptable to patient groups. A small number of women may need general anaesthesia for their examinations/treatment.
Literature
1.
go back to reference De Vuyst, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124: 1626–36. De Vuyst, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124: 1626–36.
3.
go back to reference Salit IE, Lytwyn A, Raboud J, Sano M, Chong S, et al. The role of cytology (pap tests) and human papillomavirus testing in anal cancer screening. AIDS. 2010;24:1307–13.PubMed Salit IE, Lytwyn A, Raboud J, Sano M, Chong S, et al. The role of cytology (pap tests) and human papillomavirus testing in anal cancer screening. AIDS. 2010;24:1307–13.PubMed
4.
go back to reference Berry JM, Jay N, Cranston RD, Darragh T, Holly EA, et al. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer. 2014;134:1147–55.CrossRefPubMed Berry JM, Jay N, Cranston RD, Darragh T, Holly EA, et al. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer. 2014;134:1147–55.CrossRefPubMed
5.
go back to reference Hillman RJ, Gunathilake MP, Jin F, Tong W, Field A, Carr A. Ability to detect high-grade squamous anal intraepithelial lesions at high resolution anoscopy improves over time. Sex Health. 2016;13(2):177–81.CrossRefPubMed Hillman RJ, Gunathilake MP, Jin F, Tong W, Field A, Carr A. Ability to detect high-grade squamous anal intraepithelial lesions at high resolution anoscopy improves over time. Sex Health. 2016;13(2):177–81.CrossRefPubMed
6.
go back to reference Hillman RJ, Cuming T, Darragh T, Nathan M, Berry M-L, et al. 2016 IANS international guidelines for practice standards in the detection of anal cancer precursors. J Low Genit Tract Dis. 2016;20:283–91.CrossRefPubMed Hillman RJ, Cuming T, Darragh T, Nathan M, Berry M-L, et al. 2016 IANS international guidelines for practice standards in the detection of anal cancer precursors. J Low Genit Tract Dis. 2016;20:283–91.CrossRefPubMed
7.
go back to reference Schofield AM, Sadler L, Nelson L, Gittins M, Desai M, et al. A prospective study of anal cancer screening in HIV-positive and negative MSM. AIDS. 2016;30:1375–83.CrossRefPubMed Schofield AM, Sadler L, Nelson L, Gittins M, Desai M, et al. A prospective study of anal cancer screening in HIV-positive and negative MSM. AIDS. 2016;30:1375–83.CrossRefPubMed
8.
go back to reference Silverberg MJ, Lau B, Justice AC, Engels E, et al. Risk of anal Cancer in HIV-infected and HIV-uninfected individuals in North America. CID. 2012;54(7):1026–34.CrossRef Silverberg MJ, Lau B, Justice AC, Engels E, et al. Risk of anal Cancer in HIV-infected and HIV-uninfected individuals in North America. CID. 2012;54(7):1026–34.CrossRef
9.
go back to reference Grulich AE, van Leeuwen MT, O Falster M, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67.CrossRefPubMed Grulich AE, van Leeuwen MT, O Falster M, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67.CrossRefPubMed
10.
go back to reference Duran SS, Perez N, Carrasco MG, Maldonado V, Meiller MJL, et al. HPV-related lesions in the lower genital tract of women with SLE: Significance of anoscopy. Journal of Clinical Rheumatology 2016. Conference: 19th Pan American League of Associations for Rheumatology Congress. Panama. 2016;Abstract 22(3):114. Duran SS, Perez N, Carrasco MG, Maldonado V, Meiller MJL, et al. HPV-related lesions in the lower genital tract of women with SLE: Significance of anoscopy. Journal of Clinical Rheumatology 2016. Conference: 19th Pan American League of Associations for Rheumatology Congress. Panama. 2016;Abstract 22(3):114.
11.
go back to reference Richel O, de Vries HJC, van Noesel CJM, Dijkgraaf MGW, Prins JM. Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol. 2013;14:346–53.CrossRefPubMed Richel O, de Vries HJC, van Noesel CJM, Dijkgraaf MGW, Prins JM. Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol. 2013;14:346–53.CrossRefPubMed
12.
go back to reference Tinmouth J, Raboud J, Ali M, Malloch L, Su D, et al. The psychological impact of being screened for anal cancer in HIV-infected men who have sex with men. Dis Colon rectum. 2011;54:352–9. Tinmouth J, Raboud J, Ali M, Malloch L, Su D, et al. The psychological impact of being screened for anal cancer in HIV-infected men who have sex with men. Dis Colon rectum. 2011;54:352–9.
13.
go back to reference Redelmeier DA, Kahneman D. Patients’ memories of painful medical treatments: real-time and retrospective evaluations of two minimally invasive procedures. Pain. 1996;66(1):3–8.CrossRefPubMed Redelmeier DA, Kahneman D. Patients’ memories of painful medical treatments: real-time and retrospective evaluations of two minimally invasive procedures. Pain. 1996;66(1):3–8.CrossRefPubMed
14.
go back to reference Cuming T, Nathan M. Anal cancer screening: Techniques and guidelines. Semin Colon Rectal Surg. 2017;28:69–74. Cuming T, Nathan M. Anal cancer screening: Techniques and guidelines. Semin Colon Rectal Surg. 2017;28:69–74.
15.
go back to reference Dalla Pria A, Alfa-Wali M, Fox P, Holmes P, Weir J, et al. High-resolution anoscopy screening of HIV-positive MSM: longitudinal results from a pilot study. AIDS. 2014;28:861–7.CrossRefPubMed Dalla Pria A, Alfa-Wali M, Fox P, Holmes P, Weir J, et al. High-resolution anoscopy screening of HIV-positive MSM: longitudinal results from a pilot study. AIDS. 2014;28:861–7.CrossRefPubMed
16.
go back to reference Goon P, Morrison V, Fearnhead N, Davies J, Wilson C, et al. High resolution anoscopy may be useful in achieving reductions in anal cancer local disease failure rates. Eur J Cancer Care. 2015;24(3):411–6.CrossRef Goon P, Morrison V, Fearnhead N, Davies J, Wilson C, et al. High resolution anoscopy may be useful in achieving reductions in anal cancer local disease failure rates. Eur J Cancer Care. 2015;24(3):411–6.CrossRef
Metadata
Title
The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre
Authors
Anke De-Masi
Esther Davis
Tamzin Cuming
Noreen Chindawi
Francesca Pesola
Carmelina Cappello
Susan Chambers
Julie Bowring
Adam N. Rosenthal
Peter Sasieni
Mayura Nathan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4475-6

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine